Delivery Order SPE2DB20D2002-SPE2DB23FL67T
Award Date 9/7/23
Potential Completion Date 9/8/23
Potential Value $4.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $4,922.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of July 3, 2024. The contract is not set aside for any specific business type. Amerisourcebergen also holds...
- This federal contract award, valued at $7,612.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563004203 - Ondansetron ODT 4 mg Tablet 30s, a medication used to treat nausea and vomiting. The award is a Firm Fixed Price Delivery Order with a performance period ending on December 6, 2023. The contract was awarded through full and open competition, with no set-aside designation. Amerisourcebergen...
- This federal contract award, valued at $4,739.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ondansetron ODT 4 mg Tablets, a medication commonly used to treat nausea and vomiting. The contract type is a Delivery Order with a Firm Fixed Price, and the ultimate completion date is April 22, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This federal contract award, valued at $2,986.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
- This federal contract award, valued at $5,031.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 MG tablets, a medication used to treat nausea and vomiting. The contract is a Delivery Order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and...
- This federal contract award, valued at $3,139.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting. This is a firm-fixed-price delivery order with a completion date of May 7, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $35,610.07, was issued by the Defense Logistics Agency (DLA) to the pharmaceutical distributor AmerisourceBergen Drug Corp. The contract is a Delivery Order for the supply of 4560516330 - Ondansetron ODT 4 mg Tablets, a medication commonly used to treat nausea and vomiting. The contract has an ultimate completion date of April 10, 2023 and a firm fixed price pricing type. The contract is not designated as a set-aside award. AmerisourceBergen Drug Corp holds...
- This federal contract award, worth $12,645.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a completion date of May 22, 2023 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $43,481.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559202919 - Ondansetron ODT 4 MG Tablet 30S, a pharmaceutical product used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of November 29, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award, valued at $6,572.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...